FIGURE

Fig. 2

ID
ZDB-FIG-210503-25
Publication
Peruzzo et al., 2021 - Exploiting pyocyanin to treat mitochondrial disease due to respiratory complex III dysfunction
Other Figures
All Figure Page
Back to All Figure Page
Fig. 2

Sublethal concentrations of PYO are not toxic in vitro.

a Mitochondrial ROS production by Ttc19+/− and Ttc19−/− MEFs measured by Mitosox fluorescence. Cells were either left untreated or treated with 1.5 μM PYO, and then fluorescence was monitored for 1 h. Antimycin A and rotenone were used as a positive control. Values are percentages against measurements before additions (means ± SEM, n = 4 independent replicas). b, c Quantification of lipid peroxidation in Ttc19+/− and Ttc19−/− MEFs untreated and treated with 1.5 μM PYO for 72 h (b) or for 2 months (c). Positive control: cumene hydroperoxide (CH). Data are means ± SEM. The number of the quantified images over three independent experiments is reported in the histogram . d Quantification of protein oxidation in Ttc19+/− and Ttc19−/− MEFs, both untreated and treated with 1.5 μM PYO for 72 h (means ± SEM, n = 3 independent experiments). e Representative oxyblot and quantification of protein oxidation level of Ttc19+/− and Ttc19−/− MEFs untreated and treated with 1.5 μM PYO for 2 months (means ± SEM, n = 4 independent experiments). f Representative Western blot and quantification of catalase expression in Ttc19+/− and Ttc19−/− MEF lysates untreated or treated with 1.5 μM PYO for 2 months (means ± SEM, n = 4 independent experiments). g Mitochondrial membrane potential of Ttc19−/− MEF determined by monitoring the intensity of TMRM confocal fluorescence. Scale bar: 25 μm. Positive control: FCCP-treated cells. Images are representative of two experiments. h Mitochondrial membrane potential of Ttc19+/− and Ttc19−/− MEFs by monitoring the intensity of TMRM fluorescence after 1.5 μM PYO. Values are percentages of the basal TMRM fluorescence recorded before treatments (means ± SEM, n = 10 independent experiments). i Membrane potential was measured as in (h), PYO was added 10 min after the mix of the indicated substances. The concentrations of cyanide, oligomycin, atractyloside, and rotenone were 1 mM, 0.5 μg/ml, 20 μM, and 1 μM, respectively. Data are percentages of the basal TMRM fluorescence recorded before treatments and are means ± SEM of independent experiments. Two-way ANOVA with Bonferroni post test, or one-way ANOVA with Dunnett’s multiple comparison test, or two-tailed Student’s t test were used (*p < 0.05; **p < 0.01; ***p < 0.001).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Nat. Commun.